Markers of Bone and Cartilage Turnover

被引:13
作者
Woitge, Henning W. [1 ]
Seibel, Markus J. [2 ]
机构
[1] ANZAC Res Inst, Bone Res Program, Sydney, NSW, Australia
[2] ANZAC Res Inst, Sydney, NSW 2139, Australia
关键词
bone; cartilage; metabolism; markers; osteoporosis; arthritis; OLIGOMERIC MATRIX PROTEIN; RESISTANT ACID-PHOSPHATASE; VERTEBRAL FRACTURE RISK; C-TERMINAL TELOPEPTIDE; II COLLAGEN; POSTMENOPAUSAL WOMEN; BIOCHEMICAL MARKERS; ALKALINE-PHOSPHATASE; JOINT FLUID; PROTEOGLYCAN FRAGMENTS;
D O I
10.1055/s-0043-106438
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Over the past few decades, scientists have been trying to identify tissue-specific markers that would help to better understand the pathogenesis of bone and cartilage diseases and could be used clinically for the screening, diagnosis and followup of bone or joint diseases. Historically, only a few components known to be involved in bone, mineral or cartilage turnover were available for this purpose (e.g., urine hydroxyproline, serum and urine calcium and phosphate levels). However, since most if not all of these substances have wider biological functions beyond bone, mineral and cartilage metabolism, their clinical value as tissue-specific markers was limited. Hence, there was a need to identify more specific indices of bone and cartilage metabolism. Since the 1980s, a number of collagenous and non-collagenous breakdown products as well as cell-specific enzymes have been discovered and developed into markers of musculoskeletal tissue metabolism. This review describes their chemical and biological function, available analytical methods and possible clinical applications.
引用
收藏
页码:454 / 469
页数:16
相关论文
共 161 条
[1]  
AKESSON K, 1995, J BONE MINER RES, V10, P1823
[2]   QUANTITATION OF HUMAN INTESTINAL AND LIVER BONE ALKALINE-PHOSPHATASE IN SERUM BY ROCKET ELECTROIMMUNOASSAY [J].
ALPERS, DH ;
GOODWIN, CL ;
YOUNG, GP .
ANALYTICAL BIOCHEMISTRY, 1984, 140 (01) :129-137
[3]   High Serum Sclerostin Predicts the Occurrence of Osteoporotic Fractures in Postmenopausal Women: The Center of Excellence for Osteoporosis Research Study [J].
Ardawi, Mohammed-Salleh M. ;
Rouzi, Abdulrahim A. ;
Al-Sibiani, Sharifa A. ;
Al-Senani, Nawal S. ;
Qari, Mohammed H. ;
Mousa, Shaker A. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (12) :2592-2602
[4]  
BAIS R, 1976, CLIN CHEM, V22, P2025
[5]   Classification of osteoarthritis biomarkers:: a proposed approach [J].
Bauer, D. C. ;
Hunter, D. J. ;
Abramson, S. B. ;
Attur, M. ;
Corr, M. ;
Felson, D. ;
Heinegard, D. ;
Jordan, J. M. ;
Kepler, T. B. ;
Lane, N. E. ;
Saxne, T. ;
Tyree, B. ;
Kraus, V. B. .
OSTEOARTHRITIS AND CARTILAGE, 2006, 14 (08) :723-727
[6]   Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: The fracture intervention trial [J].
Bauer, DC ;
Garnero, P ;
Hochberg, MC ;
Santora, A ;
Delmas, P ;
Ewing, SK ;
Black, DM .
JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (02) :292-299
[7]   Identification of peptide fragments generated by digestion of bovine and human osteocalcin with the lysosomal proteinases cathepsin B, D, L, H, and S [J].
Baumgrass, R ;
Williamson, MK ;
Price, PA .
JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (03) :447-455
[8]   Osteoarthritis year in review 2015: soluble biomarkers and the BIPED criteria [J].
Bay-Jensen, A. C. ;
Reker, D. ;
Kjelgaard-Petersen, C. F. ;
Mobasheri, A. ;
Karsdal, M. A. ;
Ladel, C. ;
Henrotin, Y. ;
Thudium, C. S. .
OSTEOARTHRITIS AND CARTILAGE, 2016, 24 (01) :9-20
[9]  
Billinghurst RC, 2004, METH MOLEC MED, V100, P251
[10]   Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage [J].
Billinghurst, RC ;
Dahlberg, L ;
Ionescu, M ;
Reiner, A ;
Bourne, R ;
Rorabeck, C ;
Mitchell, P ;
Hambor, J ;
Diekmann, O ;
Tschesche, H ;
Chen, J ;
VanWart, H ;
Poole, AR .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1534-1545